Before the Gut: Human Milk Oligosaccharides and Oral Microbial Colonization in Infancy
- 1Grigore T. Popa University of Medicine and Pharmacy, 700115 Iași, Romania
- 2Titu Maiorescu University, 031593 Bucharest, Romania
- 3Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
Abstract
Background/Objectives: Human milk oligosaccharides (HMOs) reach the oral cavity before any other compartment and resist hydrolysis by salivary enzymes, yet their behavior there has received far less attention than their intestinal fate. This review asks what follows from treating the mouth as a compartment rather than as a corridor. Methods: MEDLINE, Scopus and Web of Science were searched from inception to August 2026, combining oligosaccharide and oral terms, with forward citation tracking of the human studies. Each candidate mechanism was classified by its type of supporting evidence: human oral association, direct oral in vitro evidence, indirect evidence from other compartments, or unresolved hypothesis. Results: Only two human analyses, both from the same Western Australian cohort (BLOSOM), have related HMO exposure to infant oral bacterial communities; the larger concluded that the effect, while statistically detectable, was biologically limited. Residence time, and probably effective glycan concentration, differ from the intestinal case, as do the aerotolerant, Gemella- and Rothia-dominated community and the salivary films coating teeth and mucosa. In vitro, 6′-sialyllactose and free N-acetylneuraminic acid inhibited Streptococcus mutans biofilm formation, but only at concentrations (~100 mM) well above plausible oral exposure; 2′-fucosyllactose had no antibiofilm effect, reduced adhesion in two of three strains and did not support growth. Maternal FUT2 genotype shapes the oligosaccharide profile of milk, whereas the infant’s own FUT2 genotype governs fucosylation of the salivary glycoproteins those oligosaccharides encounter; neither has been measured in infant oral microbiome studies. Conclusions: Anti-adhesive and substrate-driven mechanisms may operate in parallel, and a possible asymmetry between commensal and cariogenic streptococci is framed as a testable hypothesis, as is the contribution of swallowed oral communities to gut colonization. Current evidence supports no change in practice regarding supplemented formula, donor milk, oropharyngeal colostrum, or breastfeeding and caries.
Related
- SigA forms amyloid fibrils that associate with the colicin ColE1 to support the antibacterial activity of Shigella sonnei before colonization
- Microbial communication networks governing the ecosystem dynamics of Salmonella in poultry environments: ecological interactions, colonization resistance, and emerging control strategies
- Human Milk Oligosaccharides in Exercise Nutrition: Structure-Specific Evidence, Human Efficacy, and Translational Bottlenecks
- Human Milk Oligosaccharides in Sports Nutrition: Biological Rationale and Current Evidence
- Changes in the microbial spectrum and antimicrobial resistance of bloodstream infections in intensive care units before and during the COVID-19 pandemic.
BibTeX
@article{temneanu2026before,
title = {{Before the Gut: Human Milk Oligosaccharides and Oral Microbial Colonization in Infancy}},
author = {Oana-Raluca Temneanu and Felicia Trofin and Adriana Mihai and Ancuța Lupu and Raluca Olariu and Manuela Ștefan and Elena-Roxana Buzilă and Otilia Novac and Roxana Șerban and Vasile Valeriu Lupu and Emil Anton and Mihaela Oros and Bianca Simionescu},
journal = {Nutrients},
year = {2026},
month = oct,
doi = {10.3390/nu18193269},
url = {https://europepmc.org/article/PMC/PMC13666881},
note = {CC BY},
}
RIS
TY - JOUR
TI - Before the Gut: Human Milk Oligosaccharides and Oral Microbial Colonization in Infancy
AU - Oana-Raluca Temneanu
AU - Felicia Trofin
AU - Adriana Mihai
AU - Ancuța Lupu
AU - Raluca Olariu
AU - Manuela Ștefan
AU - Elena-Roxana Buzilă
AU - Otilia Novac
AU - Roxana Șerban
AU - Vasile Valeriu Lupu
AU - Emil Anton
AU - Mihaela Oros
AU - Bianca Simionescu
PY - 2026
DA - 2026/10/01
JO - Nutrients
DO - 10.3390/nu18193269
UR - https://europepmc.org/article/PMC/PMC13666881
AB - Background/Objectives: Human milk oligosaccharides (HMOs) reach the oral cavity before any other compartment and resist hydrolysis by salivary enzymes, yet their behavior there has received far less attention than their intestinal fate. This review asks what follows from treating the mouth as a compartment rather than as a corridor. Methods: MEDLINE, Scopus and Web of Science were searched from inception to August 2026, combining oligosaccharide and oral terms, with forward citation tracking of the human studies. Each candidate mechanism was classified by its type of supporting evidence: human oral association, direct oral in vitro evidence, indirect evidence from other compartments, or unresolved hypothesis. Results: Only two human analyses, both from the same Western Australian cohort (BLOSOM), have related HMO exposure to infant oral bacterial communities; the larger concluded that the effect, while statistically detectable, was biologically limited. Residence time, and probably effective glycan concentration, differ from the intestinal case, as do the aerotolerant, Gemella- and Rothia-dominated community and the salivary films coating teeth and mucosa. In vitro, 6′-sialyllactose and free N-acetylneuraminic acid inhibited Streptococcus mutans biofilm formation, but only at concentrations (~100 mM) well above plausible oral exposure; 2′-fucosyllactose had no antibiofilm effect, reduced adhesion in two of three strains and did not support growth. Maternal FUT2 genotype shapes the oligosaccharide profile of milk, whereas the infant’s own FUT2 genotype governs fucosylation of the salivary glycoproteins those oligosaccharides encounter; neither has been measured in infant oral microbiome studies. Conclusions: Anti-adhesive and substrate-driven mechanisms may operate in parallel, and a possible asymmetry between commensal and cariogenic streptococci is framed as a testable hypothesis, as is the contribution of swallowed oral communities to gut colonization. Current evidence supports no change in practice regarding supplemented formula, donor milk, oropharyngeal colostrum, or breastfeeding and caries.
SN - 2072-6643
ER -